Call 08048952562 55% Response Rate

Send Enquiry

our range

Pain Relief Medicine

Wholesale Trader of a wide range of products which include soma dol 750 mg tablets, 500 mg sulfasalazine delayed release tablets and infimab infliximab injection 100 mg.

Soma Dol 750 Mg Tablets

  • Soma Dol 750 Mg Tablets
  • Soma Dol 750 Mg Tablets
  • Soma Dol 750 Mg Tablets
  • Soma Dol 750 Mg Tablets
Soma Dol 750 Mg Tablets
Get Best Quote
Rs 190  / PackPrice on Request

Product Brochure

Strength750 mg
BrandSuma Dol
Packaging Size10*10 Tablets
Prescription/Non prescriptionPrescription
Also givesThird Party Manufacturing
Shelf life24 Month
Country of OriginMade in India

Soma Dol 750 mg tablets are a prescription muscle relaxant used for the short-term relief of acute muscle pain, spasms, and discomfort associated with musculoskeletal conditions. The medicine works by acting on the central nervous system to help relax tense muscles and reduce pain, and it is usually prescribed alongside rest and physical therapy. The 750 mg strength is considered a higher dose and may increase the likelihood of side effects such as drowsiness, dizziness, headache, nausea, or reduced alertness. Because of its potential for dependence and sedation, Soma Dol is intended for short-term use only and should be taken strictly under medical supervision. Caution is advised when performing activities that require full concentration, such as driving or operating machinery.

View Complete details

Yes! I am Interested Request a call back

500 Mg Sulfasalazine Delayed Release Tablets

  • 500 Mg Sulfasalazine Delayed Release Tablets
  • 500 Mg Sulfasalazine Delayed Release Tablets
500 Mg Sulfasalazine Delayed Release Tablets
Get Best Quote
Rs 90  / BoxPrice on Request

Product Brochure

Strength500 mg
Packaging Size100 Tablets
Brandsaaz 500mg
Manufactureripca
Composition500 Mg Sulfasalazine Delayed Release Tablets
Treatmentclass of anti-inflammatory medicines

500 mg Sulfasalazine Delayed-Release Tablets are a prescription medicine used to treat inflammatory conditions of the intestines, such as ulcerative colitis, and certain types of arthritis, including rheumatoid arthritis. The active ingredient, sulfasalazine, works by reducing inflammation in the affected areas of the body. The delayed-release formulation allows the medicine to pass through the stomach and release slowly in the intestines, where it is most effective. The tablets are taken orally, usually with or after food, as directed by a doctor. Common side effects may include nausea, headache, loss of appetite, or mild stomach upset. Sulfasalazine is prescription-only and should be used under medical supervision, with regular monitoring to ensure safety and effectiveness.

View Complete details

Yes! I am Interested Request a call back

Infimab Infliximab Injection 100 Mg

Infimab Infliximab Injection 100 Mg
Get Best Quote
Rs 17,000  / VialPrice on Request

Minimum Order Quantity: 1 Vial

BrandInfimab
Packaging TypeVial
ManufacturerRanbaxy
Shelf Life24 Months
Usage/ApplicationRheumatoid Arthritis, Ankylosing spondylitis, ulcerative colitis, psoriatic arthritis
Prescription/Non prescriptionPrescription
Infimab (Infliximab) 100 mg Injection is a prescription biologic medicine containing infliximab, a monoclonal antibody that targets and blocks tumour necrosis factor‑alpha (TNF‑α)—a key protein involved in driving inflammation in the immune system. By neutralizing TNF‑α, this medicine helps reduce inflammation, swelling and immune‑mediated damage in a range of autoimmune and inflammatory conditions, especially when other treatments haven’t worked well. It is most commonly used to manage moderate‑to‑severe rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, chronic plaque psoriasis, Crohn’s disease and ulcerative colitis, providing relief from pain, stiffness and gastrointestinal symptoms while slowing disease progression. 

Additional Information:

  • Delivery Time: 15-20 days
  • Packaging Details: 1 vail

View Complete details

Yes! I am Interested Request a call back

EXPLORE MORE CATEGORIES